arrow
F

Francesca Felicia Operto

Magna Graecia University
H指数:30
被引数:3,417

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DECREASE study: A European pool-analysis of patients with significant reductions in concomitant antiseizure medications in cenobamate Early Access Programs

DECREASE研究:一项关于cenobamate早期准入计划中联用抗癫痫药物显著减少的欧洲合并分析

2026-09-180
OAAI
Expanding clinical variability in FBXW7-related neurodevelopmental disorder: a multicenter case series

FBXW7相关神经发育障碍的临床表型多样性扩展:一项多中心病例系列研究

2026-07-100
OAAI
Real-world effectiveness and tolerability of highly purified cannabidiol in patients with monogenic developmental and epileptic encephalopathies with highly active epilepsy

高纯度大麻二酚在单基因发育性癫痫性脑病伴高度活跃癫痫患者中的实际有效性与耐受性

2026-07-011
OAAI
Behind the seizures: Exploring the emotional burden of adolescents with idiopathic generalized epilepsy

癫痫发作的背后:探索特发性全面性癫痫青少年的情感负担

2026-07-010
OA
Real-world effectiveness of highly purified cannabidiol in epilepsy associated with 15q11.2-q13.1 duplication and deletion syndromes: A multicenter study

高纯度大麻二酚在15q11.2-q13.1重复和缺失综合征相关癫痫中的真实世界有效性:一项多中心研究

2026-04-160
OAAI
In search of what really matters: Insights from a web-based survey on Patient-Centered Outcomes in GLUT1DS

寻求真正重要的因素:来自GLUT1DS患者为中心结局的网络调查的见解

2026-02-011
PRE
Predicting epilepsy after new onset refractory status epilepticus due to autoimmune encephalitis: The DAME score
2025-12-010
OAAI
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy

拉考沙胺在治疗12个月时的持续性高于布瓦雷萨坦和珀马panel,尽管其疗效相似。

2025-11-200
OAAI
Clinical predictors and concomitant antiseizure medications effects on seizure control in relation to plasma cenobamate concentration: a multicenter retrospective study

临床预测因子及合并使用的抗癫痫药物对血浆cenobamate浓度相关癫痫控制的影响:一项多中心回顾性研究

2025-09-220
OAAI
Phenotypic traits and family history in patients with 22q11.2 deletion syndrome and generalized epilepsy: A multicenter case-control study
2024-12-240
PRE
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program
2024-08-143
OAAI
Lamotrigine vs levetiracetam in female patients of childbearing age with juvenile absence epilepsy: A Bayesian reanalysis
2024-08-102
PRE
Predictors of Seizure Recurrence in Women With Idiopathic Generalized Epilepsy Who Switch From Valproate to Another Medication
2024-05-145
PRE
Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: Does effectiveness offset the teratogenic risks?
2024-01-312
PRE
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study
2023-12-1611
OAAI